- Home
- ANY vs TRIB Comparison
ANY vs TRIB Comparison
Compare ANY & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ANY | TRIB |
|---|---|---|
| Founded | N/A | 1992 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.1M | 6.1M |
| IPO Year | 2020 | 1996 |
Fundamental Metrics
Financial Performance| Metric | ANY | TRIB |
|---|---|---|
| Price | $2.12 | $12.12 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $30.00 | N/A |
| AVG Volume (30 Days) | ★ 614.4K | 160.7K |
| Earning Date | 05-05-2026 | 05-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $11,181,000.00 | N/A |
| Revenue This Year | $15.62 | $13.51 |
| Revenue Next Year | N/A | $13.14 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.16 | $0.28 |
| 52 Week High | $6.20 | $14.17 |
Technical Indicators
Market Signals| Indicator | ANY | TRIB |
|---|---|---|
| Relative Strength Index (RSI) | 50.36 | 80.22 |
| Support Level | $1.30 | $0.58 |
| Resistance Level | $2.48 | $14.17 |
| Average True Range (ATR) | 0.28 | 1.20 |
| MACD | 0.08 | 0.55 |
| Stochastic Oscillator | 74.72 | 81.78 |
Price Performance
Historical ComparisonAbout ANY Sphere 3D Corp.
Sphere 3D Corp is engaged in the Bitcoin mining business. The company has established an enterprise-scale mining operation through the procurement of mining equipment and partnering with experienced service providers. It generates revenue from mining and selling Bitcoin.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has three segments, namely the Americas, Asia/Africa, and Europe, from which it derives a majority of its revenue from the Americas segment.